NCT05905640

Brief Summary

The goal of this cluster randomized study is to understand if using a One stop PrEP delivery model can improve the efficiency of PrEP service delivery, reduce the cost of providing PrEP and allow continuation on PrEP. The investigators will evaluate data from men and women ≥15 years of age unknown to be living with HIV seeking PrEP services at public health facilities in western Kenya.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,400

participants targeted

Target at P75+ for not_applicable hiv-infections

Timeline
15mo left

Started Jan 2024

Typical duration for not_applicable hiv-infections

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress66%
Jan 2024Jul 2027

First Submitted

Initial submission to the registry

May 12, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 15, 2023

Completed
7 months until next milestone

Study Start

First participant enrolled

January 1, 2024

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2027

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2027

Last Updated

April 17, 2025

Status Verified

April 1, 2025

Enrollment Period

3.3 years

First QC Date

May 12, 2023

Last Update Submit

April 14, 2025

Conditions

Keywords

PrEPHIV PreventionPrEP adherenceSexual behavior

Outcome Measures

Primary Outcomes (9)

  • PrEP initiation

    PrEP initiation will be measured by client start of PrEP use documented on the ministry of health (MOH) tools. Data will be abstracted from MOH tools by project dedicated staff from up to 2400 persons newly initiating PrEP at the participating clinics.

    Years 2-4 of the study, up to 36 months.

  • PrEP continuation

    PrEP continuation will determined by clinic visit attendance and pharmacy PrEP refills records obtained by abstraction of MOH clinic records.

    up to 12 months of PrEP use.

  • PrEP adherence

    PrEP adherence will be measured objectively by quantification of drug levels in dried blood spots obtained at random subset visits from clients returning for PrEP refills.

    Years 2-4 of the study, up to 36 months.

  • Acceptability

    Acceptability will be determined as the perception among clients, providers, and stakeholder that one-stop PrEP services is agreeable to them. Mixed methods assessments, including user and provider surveys and qualitative interviews with users and providers will be utilized to measure acceptability. The Proctors implementation framework will be utilized to organize outcomes and to understand acceptability of one-stop and quality improvement measures at the user, clinic, and provider level. Investigators will comprehensively triangulate all data sources to understand how system, provider, and client factors interact to influence adoption.

    Throughout the study period, up to 36 months

  • Adoption

    Adoption will be determined as the proportion and characteristics of facilities adopting one-stop services. Mixed methods assessments, including provider surveys and qualitative interviews with users and providers will be utilized to measure adoption. The Proctors implementation framework will be utilized to organize outcomes and to understand adoption of one-stop and quality improvement measures at the clinic and provider level. Investigators will comprehensively triangulate all data sources to understand how system, provider, and client factors interact to influence adoption.

    Throughout the study period, up to 36 months

  • Fidelity

    Fidelity will be defined as the degree to which one-stop pathway and quality improvement measures are implemented as planned. Checklists and technical assistant (TA) reports will be used to study how implementation of one-stop pathway and quality improvement measures are implemented per protocol at provider and clinic level. Investigators will comprehensively triangulate all data sources to understand how system, provider, and client factors interact to influence adoption.

    Throughout the study period, up to 36 months

  • Total client wait time and staff time spent on PrEP services

    Efficiency will be defined as client wait time and staff time spent on PrEP services. Time will be done by observing at least 50 clinical visits per arm to assess wait time and staff time spent on counseling, HIV testing, clinical review, and PrEP provision

    Throughout the study period, up to 36 months

  • Satisfaction with services

    Satisfaction will be defined ad fulfillment or happiness with one-stop service experience. Within the program we will use cross-sectional quantitative exit surveys administered to random clients at clinic to understand quality of care services and satisfaction with services.

    Throughout the study period, up to 36 months

  • Sustainability

    Sustainability will be defined as the number of clinics using one-stop at 6, 12 months after technical assistance (TA). Checklists and technical assistant reports will be used to document implementation of one-stop after technical assistance support is scaled back The Proctors implementation framework will be used to organize implementation outcomes. Investigators will comprehensively triangulate all data sources to understand how system, provider, and client factors interact to influence continuation of PrEP.

    up to 12 months after technical assistance support is scaled back

Secondary Outcomes (1)

  • Incremental cost of one-stop PrEP services, including costs averted, and reduced client wait times.

    up to 36 months.

Study Arms (2)

Control arm- Usual PrEP care pathway

NO INTERVENTION

At clinics that will serve as contemporaneous control clinics, eligible persons will receive PrEP according to the current client flow, which typically involves multiple room consultations. Quality improvement strategies will be promoted throughout the implementation period.

Intervention Arm- One Stop PrEP care pathway

OTHER

In a one-stop arm, the number of client consultation rooms in the PrEP care pathway will be reduced to a single consultation room. All core PrEP services that include HIV testing, risk assessment, clinical review PrEP initiation, prescription, dispensing, and follow-up will be performed in a one-stop consultation with a single provider. Quality improvement strategies will be promoted throughout the implementation period.

Other: Method of PrEP delivery and consultation

Interventions

All core PrEP services that include HIV testing, risk assessment, clinical review PrEP initiation, prescription, dispensing, and follow-up will be performed in a one-stop consultation with a single provider.

Intervention Arm- One Stop PrEP care pathway

Eligibility Criteria

Age15 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • ≥15 years of age
  • Accessing PrEP services at implementing clinics.
  • Eligible for PrEP per Kenya national guidelines
  • For in-depth and key delivery informant interviews
  • Able and willing to provide consent
  • Provides services at participating clinics (healthcare providers)
  • Key policy maker

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kenya Medical Research Institute -KEMRI

Kisumu, Kenya

RECRUITING

MeSH Terms

Conditions

HIV InfectionsSexual Behavior

Interventions

Referral and Consultation

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesBehavior

Intervention Hierarchy (Ancestors)

Professional PracticeOrganization and AdministrationHealth Services Administration

Study Officials

  • Kenneth Mugwanya, MBChB, MS, PhD

    University of Washington

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jennifer Morton

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Cluster randomized trial of twelve public health clinics assigned 1:1 to implement either the intervention of One stop PrEP care pathway or usual clinic flow as control.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor: Global Health

Study Record Dates

First Submitted

May 12, 2023

First Posted

June 15, 2023

Study Start

January 1, 2024

Primary Completion (Estimated)

April 30, 2027

Study Completion (Estimated)

July 31, 2027

Last Updated

April 17, 2025

Record last verified: 2025-04

Locations